COPD in the News Your source for COPD-related news from around the web.

Not sure what to submit? Read our news guidelines first.

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia


Chronic obstructive pulmonary disease (COPD) is associated with eosinophilic airway inflammation in 10-20% of patients. Benralizumab, a monoclonal antibody, has been shown to decrease the number of blood and sputum eosinophils. In this trial of 101 patients with COPD whether benralizumab reduces the number of acute exacerbations was investigated.

Views 35 Comments 0 Likes 0
12 days

Propeller Health Raises $14.5 Million Series B Financing Led by Safeguard Scientifics


MADISON, Wisc. and WAYNE, Penn., Sept. 4, 2014 /PRNewswire/ — Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, today announced that it raised $14.5 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership.

Views 44 Comments 0 Likes 0
16 days

Combination therapy for COPD associated with better outcomes


Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists (LABAs) and inhaled corticosteroid combination therapy, compared with newly prescribed LABAs alone, was associated with a lower risk of death or COPD hospitalization, according to a study in the September 17 issue of…

Views 12 Comments 0 Likes 0
2 days
Hide the Social Toolbar Show the Social Toolbar